Why ArriVent BioPharma, Inc. (AVBP) stock fell 11.2% on Monday, November 16, 2026

ArriVent BioPharma, Inc. (AVBP) closed at $11.56, down 11.15% on Monday, November 16, 2026, on volume of 642,464 shares (0.5× its 3-month average); market value about $600.0M, according to Nexqual market data (nexqual.com/moves/2026-11-16/AVBP).

What happened

Nexqual found no SEC filing, earnings release, analyst rating change or insider trade for AVBP on Monday, November 16, 2026 or November 13, 2026. The move may reflect news, sector or market moves, or trading flows that these sources do not capture.

More on AVBP

AVBP stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 16, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:48 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 18, 2026 at 20:48 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt